LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set
K-Number: K162969 · 2017-01-06
Device Summary
Frequently Asked Questions
What is the LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set?
LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set is a medical device that received FDA 510(k) clearance on 2017-01-06. It is manufactured by DiaSorin, Inc.. The 510(k) number is K162969.
When was LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set approved by the FDA?
LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set received FDA 510(k) clearance on 2017-01-06, under approval number K162969.
What company makes LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set?
LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set is manufactured by DiaSorin, Inc..
What is the FDA product code for LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set?
The FDA product code for LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set is LFZ.
Related Clinical Trials
Other Devices by DiaSorin, Inc.
Related Devices (Code: LFZ)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.